Zydus Lifesciences Ltd releases Consolidated Financial Results for December 31, 2022.
Financial Results (Q3 FY2023) – Quarter-over-Quarter Comparison:
Total income of Zydus Lifesciences Ltd is Rs.4400.8 Crores (December 31, 2022) vs. Rs.4179.1 Crores (September 30, 2022)
Net profit/loss: Rs.622.9 Crores (December 31, 2022) vs. Rs.522.5 Crores (September 30, 2022)
EPS: Rs.6.15 (December 31, 2022) vs. Rs.5.15 (September 30, 2022)
Financials | Q3 FY2023 | Q2 FY2023 | % Change |
Total Income | ₹4400.8 Cr | ₹4179.1 Cr | ⬆ 5.30% |
Net Profit | ₹622.9 Cr | ₹522.5 Cr | ⬆ 19.22% |
EPS | ₹6.15 | ₹5.15 | ⬆ 19.42% |
Financial Results (Q3 FY2023) – Year-over-Year Comparison:
Total income of Zydus Lifesciences Ltd is Rs.4400.8 Crores (December 31, 2022) vs. Rs.3700.5 Crores (December 31, 2022)
Net profit/loss: Rs.622.9 Crores (December 31, 2022) vs. Rs.500.4 Crores (December 31, 2022)
EPS: Rs.6.15 (December 31, 2022) vs. Rs.4.89 (December 31, 2022)
Financials | Q3 FY2023 | Q3 FY2022 | % Change |
Total Income | ₹4400.8 Cr | ₹3700.5 Cr | ⬆ 18.92% |
Net Profit | ₹622.9 Cr | ₹500.4 Cr | ⬆ 24.48% |
EPS | ₹6.15 | ₹4.89 | ⬆ 25.77% |
Financial Results (9 Months Ended FY2023) – Year-over-Year Comparison:
Total income of Zydus Lifesciences Ltd is Rs.12718.5 Crores (December 31, 2022) vs. Rs.11547 Crores (December 31, 2021)
Net profit/loss: Rs.1663.7 Crores (December 31, 2022) vs. Rs.4089.9 Crores (December 31, 2021)
EPS: Rs.16.36 (December 31, 2022) vs. Rs.39.95 (December 31, 2021)
Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
Total Income | ₹12718.5 Cr | ₹11547 Cr | ⬆ 10.15% |
Net Profit | ₹1663.7 Cr | ₹4089.9 Cr | ⬇ -59.32% |
EPS | ₹16.36 | ₹39.95 | ⬇ -59.09% |
For More Latest News Click Here